Retired PwC Tax Partner, Ken Hagen, joins the board of AMRI

 In PricewaterhouseCoopers, PwC

AMRI has announced the appointment of Kenneth P. Hagen, a former tax partner at PwC, to its Board of Directors. Mr. Hagen will join AMRI’s board in May 2016.

Mr. Hagen joined PwC in 1975 and became a tax partner in 1986, serving a wide range of pharmaceutical, industrial and technology clients. Since 2000 and until his retirement in 2011, Ken was the Partner-in-Charge of PwC’s Mergers and Acquisition tax practice in Philadelphia. In addition, Ken served as principal tax advisor for over a decade to one of the world’s leaders in generic pharmaceuticals. He also advised other clients on tax issues associated with large and diverse corporate transactions. Mr. Hagen is a CPA and holds a BS in Accounting from Pennsylvania State University and a Masters in Taxation from Villanova University.

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades.

Contact Us

Send us an email and we'll get back to you, asap.

Start typing and press Enter to search